Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
MARKETS
SECTOR : PHARMA & BIOTECH
INDUSTRY : MAJOR PHARMACEUTICALS
GENMAB - ADR
Genmab - ADR
XNAS: GMAB
Mid-range Performer
Download real time
26.07
-0.99
(
-3.66
%)
26.42% Fall from 52W High
4.5M
XNAS Volume
High volume today
XNAS
08 May, 2026 3:12 PM (EDT)
Watchlist
Portfolio
Alert
My Notes
Board Meeting
The board meeting for Genmab (ADR) is scheduled for today, for the purpose of Genmab AS First Quarter Earnings Results for 2026
See details
Overview
Buy Sell Zone
Financials
Charts & Report
Charts and Graphs
Technicals
Price History/Seasonality
Ownership
Politician Trades
Insider Deals
Corporate Actions
All
Dividend
Split
Board Meetings
About
Genmab (ADR) - GMAB - stock price prediction, stock price target, analyst ratings from 11 analysts
Genmab (ADR) has a share price target of US$ 38, revenue growth forecast of 17.4%, and profit growth estimate of -28.2% for FY26, based on top 11 analyst calls.
Forecaster Screeners